Veterinary Pharmacovigilance

Veterinary pharmacovigilance is the process of monitoring the safety of veterinary drugs and ensuring that they are used safely and effectively in animals. It involves the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems in animals. The goal of veterinary pharmacovigilance is to ensure that veterinary drugs are safe and effective for use in animals, and to minimize the risk of harm to animals and humans.

Some key components of veterinary pharmacovigilance include:

  1. Monitoring adverse drug reactions (ADRs): Veterinarians and animal owners can report any suspected adverse reactions to veterinary drugs to the regulatory authorities, such as the FDA in the United States, or the EMA in Europe. These reports are used to identify potential safety concerns and to take appropriate regulatory action, such as changing the product label or withdrawing the drug from the market.
  2. Post-marketing surveillance: After a drug is approved for use in animals, its safety is continuously monitored through post-marketing surveillance programs. These programs are designed to identify any new or previously unrecognized adverse effects that may occur after the drug is released to the market.
  3. Risk management: Veterinary pharmacovigilance involves the development of risk management plans to minimize the risk of harm to animals and humans. This includes measures such as the development of product labels and instructions for use, the education of veterinarians and animal owners about the safe use of drugs, and the development of tools to monitor and detect adverse effects.
  4. Collaboration with other stakeholders: Veterinary pharmacovigilance involves collaboration between regulatory authorities, veterinary professionals, animal owners, and pharmaceutical companies to ensure that veterinary drugs are safe and effective for use in animals.

Overall, veterinary pharmacovigilance plays a critical role in ensuring the safety and efficacy of veterinary drugs, and is an important part of the regulatory framework for animal health.

    Related Conference of Veterinary Pharmacovigilance

    September 26-27, 2024

    10th Annual Summit on Animal Health and Veterinary Medicine

    Amsterdam, Netherlands

    Veterinary Pharmacovigilance Conference Speakers